Literature DB >> 9432672

[Sclerosing polycystic sialadenopathy. A rare non-tumorous disease].

K Donath1, G Seifert.   

Abstract

Tumour-like lesions of the salivary glands are diseases which, in accordance with the new WHO classification of salivary gland tumours, can simulate a true tumour by swelling or induration of the salivary gland tissue. An additional rare entity, only recently not described in the new WHO classification, is "sclerosing polycystic sialadenopathy" (s.p.s.) which, especially in younger patients, results in nodular, incompletely encapsulated, tumour-like masses mainly of the parotid gland. Histologically, it is comparable to fibrocystic mastopathy and is characterized by distinct hyalinized, centrally accentuated sclerosing collageneous tissue with inclusion of cystically ectatic ducts and focal epithelial hyperplasia. In the hyperplastic ducts, trans-luminal bridges and cribriform patterns can develop, sometimes also apocrine secretion and eosinophilic globules. The s.p.s. must be distinguished mainly from cystadenoma, mucoepidermoid carcinoma and also from dysgenetic cystic parotid gland. Based on four of our own observations the differential diagnosis is analysed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9432672     DOI: 10.1007/s002920050228

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  3 in total

1.  Parotid lipoadenoma with sclerotic and polycystic changes.

Authors:  Mitsuyoshi Hirokawa; Yoshimi Bando; Takashi Tashiro; Seiji Kuma; Ikuji Kawata; Toshiaki Sano
Journal:  Virchows Arch       Date:  2002-02-08       Impact factor: 4.064

Review 2.  Newly described salivary gland tumors.

Authors:  Alena Skalova; Michal Michal; Roderick Hw Simpson
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

Review 3.  [Diagnosis and prognosis of salivary gland tumors. An interpretation of new revised WHO classification].

Authors:  G Seifert
Journal:  Mund Kiefer Gesichtschir       Date:  1997-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.